With the increasing age of patients with pulmonary arterial hypertension (PAH) at diagnosis, multiple comorbidities are more and more common in these patients, especially cardiopulmonary diseases. This article introduces the incidence of PAH combined with cardiovascular disease and/or chronic lung disease, elaborates on the impact of cardiopulmonary comorbidities on the diagnosis, prognosis, and targeted drug treatment strategies of PAH, and proposes management recommendations for PAH patients with comorbidities, aiming to further improve the diagnosis and treatment level of pulmonary hypertension.
随着动脉型肺动脉高压（PAH）患者确诊时的年龄越来越大，伴有多种共病越来越常见，特别是心肺疾病。伴有或不伴心肺疾病PAH患者的诊断和治疗策略不同。本文介绍了PAH合并心血管疾病和（或）慢性肺部疾病的发生率，阐述了心肺共病对PAH的诊断、预后和靶向药物治疗策略的影响，提出了针对合并心肺共病PAH患者的管理建议，旨在进一步提高肺动脉高压的诊治水平。.